ICAM1 and breast cancer: Previous studies have shown that STAT3 and NFKB2 are drivers of immunosuppressive activation in MDSCs,[34, 35] whereas TCF21 and TWIST2 are associated with EMT.[27, 36] These findings suggest that the subset of ICAM1+ iCAFs plays a critical role in the recurrence of BC.